Synthetic regulatory RNAs selectively suppress the progression of bladder cancer

[1]  Li Tang,et al.  microRNA inhibitors: Natural and artificial sequestration of microRNA. , 2017, Cancer letters.

[2]  Hong-zhao Li,et al.  MicroRNAs with prognostic significance in bladder cancer: a systematic review and meta-analysis , 2017, Scientific Reports.

[3]  Xiuheng Liu,et al.  MicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1 oncogene , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[4]  G. Kristiansen,et al.  The translational potential of microRNAs as biofluid markers of urological tumours , 2016, Nature Reviews Urology.

[5]  Zhen Xie,et al.  Construction and Characterization of a Synthetic MicroRNA Cluster for Multiplex RNA Interference in Mammalian Cells. , 2016, ACS synthetic biology.

[6]  Jianhua Shi,et al.  miR-451 suppresses bladder cancer cell migration and invasion via directly targeting c-Myc. , 2016, Oncology reports.

[7]  Z. Cai,et al.  Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer. , 2016, Cancer letters.

[8]  K. Aldape,et al.  TERT Promoter Mutations and Risk of Recurrence in Meningioma. , 2016, Journal of the National Cancer Institute.

[9]  Yuchen Liu,et al.  Synthetic Bax-Anti Bcl2 combination module actuated by super artificial hTERT promoter selectively inhibits malignant phenotypes of bladder cancer , 2016, Journal of experimental & clinical cancer research : CR.

[10]  Xianjun Chen,et al.  Synthetic dual-input mammalian genetic circuits enable tunable and stringent transcription control by chemical and light , 2015, Nucleic acids research.

[11]  Z. Cai,et al.  Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells , 2015, Oncotarget.

[12]  C. Dang,et al.  MYC, Metabolism, and Cancer. , 2015, Cancer discovery.

[13]  D. Bonatto,et al.  Scaffolds for Artificial miRNA Expression in Animal Cells. , 2015, Human gene therapy methods.

[14]  Taraka Dale,et al.  Tunable Riboregulator Switches for Post-transcriptional Control of Gene Expression. , 2015, ACS synthetic biology.

[15]  Li Liu,et al.  Synthetic miRNA sponges driven by mutant hTERT promoter selectively inhibit the progression of bladder cancer , 2015, Tumor Biology.

[16]  Ron Weiss,et al.  Highly-efficient Cas9-mediated transcriptional programming , 2014, Nature Methods.

[17]  Z. Cai,et al.  Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells , 2014, Nature Communications.

[18]  Z. Cai,et al.  Telomerase reverse transcriptase gene promoter mutations help discern the origin of urogenital tumors: a genomic and molecular study. , 2014, European urology.

[19]  Christof Fellmann,et al.  An optimized microRNA backbone for effective single-copy RNAi. , 2013, Cell reports.

[20]  S. Gabriel,et al.  Pan-cancer patterns of somatic copy-number alteration , 2013, Nature Genetics.

[21]  L. Bleris,et al.  Transcripts for combined synthetic microRNA and gene delivery. , 2013, Molecular bioSystems.

[22]  W. Cho.  MicroRNAs as therapeutic targets and their potential applications in cancer therapy , 2012, Expert opinion on therapeutic targets.

[23]  G. Marta,et al.  The role of radiotherapy in urinary bladder cancer: current status. , 2012, International braz j urol : official journal of the Brazilian Society of Urology.

[24]  E. Sacco,et al.  Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer , 2012, Urologia Internationalis.

[25]  Zhen Xie,et al.  Multi-Input RNAi-Based Logic Circuit for Identification of Specific Cancer Cells , 2011, Science.

[26]  Danish Sayed,et al.  MicroRNAs in development and disease. , 2011, Physiological reviews.

[27]  Johannes Zuber,et al.  A Rapid and Scalable System for Studying Gene Function in Mice Using Conditional RNA Interference , 2011, Cell.

[28]  Yingbei Chen,et al.  Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy , 2010, Cancer.

[29]  W. Filipowicz,et al.  The widespread regulation of microRNA biogenesis, function and decay , 2010, Nature Reviews Genetics.

[30]  W. Cho.  MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. , 2010, The international journal of biochemistry & cell biology.

[31]  J. Montie,et al.  Bladder Cancer in 2010: How Far have We Come? , 2010, Ca.

[32]  G. Risuleo,et al.  The synthetic inhibitor of Fibroblast Growth Factor Receptor PD166866 controls negatively the growth of tumor cells in culture , 2009, Journal of experimental & clinical cancer research : CR.

[33]  W. Jones,et al.  The expanding reach of the GAL4/UAS system into the behavioral neurobiology of Drosophila. , 2009, BMB reports.

[34]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[35]  K. Kawakami,et al.  Targeted gene expression by the Gal4‐UAS system in zebrafish , 2008, Development, Growth and Differentiation.

[36]  Brian L. Gilmore,et al.  Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi , 2008, Proceedings of the National Academy of Sciences.

[37]  C. Harley,et al.  Telomerase and cancer therapeutics , 2008, Nature Reviews Cancer.

[38]  Detlef Weigel,et al.  Gene silencing in plants using artificial microRNAs and other small RNAs. , 2008, The Plant journal : for cell and molecular biology.

[39]  R. Verdun,et al.  Replication and protection of telomeres , 2007, Nature.

[40]  S. Elledge,et al.  A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Farren J. Isaacs,et al.  Engineered riboregulators enable post-transcriptional control of gene expression , 2004, Nature Biotechnology.

[42]  K. Grigor,et al.  Genetic aberrations of c-myc and CCND1 in the development of invasive bladder cancer , 2002, British Journal of Cancer.

[43]  G. F. Joyce.  The antiquity of RNA-based evolution , 2002, Nature.

[44]  S. Eddy.  Non–coding RNA genes and the modern RNA world , 2001, Nature Reviews Genetics.

[45]  R. Reddel.  Telomerase and cancer. , 1997, Japanese journal of cancer research : Gann.

[46]  N. Perrimon,et al.  Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. , 1993, Development.